- Home
- SPRC vs GRI Comparison
SPRC vs GRI Comparison
Compare SPRC & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRC
- GRI
- Stock Information
- Founded
- SPRC 2004
- GRI 2018
- Country
- SPRC Israel
- GRI United States
- Employees
- SPRC N/A
- GRI N/A
- Industry
- SPRC Biotechnology: Pharmaceutical Preparations
- GRI Biotechnology: Pharmaceutical Preparations
- Sector
- SPRC Health Care
- GRI Health Care
- Exchange
- SPRC Nasdaq
- GRI Nasdaq
- Market Cap
- SPRC 3.4M
- GRI 3.2M
- IPO Year
- SPRC N/A
- GRI N/A
- Fundamental
- Price
- SPRC $0.30
- GRI $1.26
- Analyst Decision
- SPRC
- GRI Strong Buy
- Analyst Count
- SPRC 0
- GRI 2
- Target Price
- SPRC N/A
- GRI $22.00
- AVG Volume (30 Days)
- SPRC 196.1K
- GRI 112.3K
- Earning Date
- SPRC 02-15-2025
- GRI 08-13-2025
- Dividend Yield
- SPRC N/A
- GRI N/A
- EPS Growth
- SPRC N/A
- GRI N/A
- EPS
- SPRC N/A
- GRI N/A
- Revenue
- SPRC $1,306,000.00
- GRI N/A
- Revenue This Year
- SPRC N/A
- GRI N/A
- Revenue Next Year
- SPRC N/A
- GRI N/A
- P/E Ratio
- SPRC N/A
- GRI N/A
- Revenue Growth
- SPRC N/A
- GRI N/A
- 52 Week Low
- SPRC $0.20
- GRI $1.10
- 52 Week High
- SPRC $1.79
- GRI $43.69
- Technical
- Relative Strength Index (RSI)
- SPRC 49.11
- GRI 40.16
- Support Level
- SPRC $0.29
- GRI $1.28
- Resistance Level
- SPRC $0.34
- GRI $1.45
- Average True Range (ATR)
- SPRC 0.02
- GRI 0.11
- MACD
- SPRC -0.00
- GRI 0.03
- Stochastic Oscillator
- SPRC 33.33
- GRI 29.30
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.